01/28/2025
9:46 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/28/2025
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025
4:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/16/2025
8:20 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025
8:22 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/14/2025
3:27 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:04 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:14 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/07/2025
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:52 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:54 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
|
12/30/2024
5:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
12/23/2024
3:04 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
3:23 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K/A | |
12/19/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
7:32 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
12/17/2024
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:32 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
12/10/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K/A | |
12/03/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
11:15 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form EFFECT | |
11/21/2024
3:01 PM | Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/18/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
4:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:27 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024
3:30 PM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
11/05/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
6:39 PM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
11/04/2024
5:20 PM | Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/04/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:02 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
10/28/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024
3:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
10/22/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
4:19 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/18/2024
3:31 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
12:24 PM | ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G | |
10/15/2024
8:09 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Is this the pin that pops the bubble? (Ad) CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia…
In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers.
Go here now before it’s too late to find out why Nvidia shares are slumping so hard. Go Here Now Before It’s Too Late |
10/11/2024
6:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
4:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/26/2024
3:40 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
8:16 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/01/2024
7:26 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 424B5 | |
07/01/2024
7:09 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
3:54 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
11:15 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form EFFECT | |
06/25/2024
3:31 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:28 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
8:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
4:25 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
8:10 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
4:16 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
3:11 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
6:37 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G | |
03/22/2024
9:24 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 424B5 | |
03/21/2024
4:14 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:58 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
8:06 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
8:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
